Related Experiment Video
Updated: Dec 23, 2025

Capture and Release of Viable Circulating Tumor Cells from Blood
Published on: October 28, 2016
Augmented teicoplanin clearance through probable adsorption onto a polymethyl methacrylate (PMMA) hemofilter during
Kazutaka Oda1, Hirofumi Jono1, Katsuyuki Sagishima2
1Department of Pharmacy, Kumamoto University Hospital, 1-1-1, Honjo, Chuo-ku, Kumamoto City, Kumamoto, 860-8556, Japan.
Abstract:
Teicoplanin, a glycopeptide antibiotic against Gram-positive bacteria, is used during continuous venovenous hemodiafiltration (CVVHDF), though adsorption onto a hemofilter has been observed in an in-vitro study. We report a case of extensive augmentation of teicoplanin clearance by a polymethyl methacrylate (PMMA) hemofilter. A 74-year-old man (body weight 53 kg) was performed CVVHDF with the PMMA hemofilter. The effluent flow rate maintained at 600-650 mL/h. The measured teicoplanin clearance was 31.0 mL/min, and the clearance was reduced to 11.1 mL/min over the next 6.5 hours. In conclusion, we should closely monitor teicoplanin dosing during CVVHDF using a PMMA membrane hemofilter.
Insights
Teicoplanin clearance significantly increased during continuous venovenous hemodiafiltration (CVVHDF) with a polymethyl methacrylate (PMMA) hemofilter. Close monitoring of teicoplanin dosage is crucial when using PMMA membranes in CVVHDF patients.
Area of Science:
- Pharmacokinetics
- Nephrology
- Infectious Diseases
Background:
- Teicoplanin is a glycopeptide antibiotic effective against Gram-positive bacteria.
- Continuous venovenous hemodiafiltration (CVVHDF) is a renal replacement therapy.
- In-vitro studies suggest teicoplanin may adsorb to hemofilters.
Related Concept Videos
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration
Drug Elimination by Renal Route: Tubular Secretion
Continuous Renal Replacement Therapy
Drug Elimination by Renal Route: Tubular Reabsorption
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions

